FDA opens up competition for pregnancy drug
Wednesday, March 30, 2011 - 23:00
in Mathematics & Economics
The drug maker K-V Pharmaceutical obtained exclusive rights to produce an injection for women at high risk of delivering prematurely. But the FDA is opening up the market to specialty pharmacies after the company raised the dosage price from $20 to $1,500.The Food and Drug Administration took the unusual step Wednesday of inviting specialty pharmacies to make an end run around a company that obtained exclusive rights to a pregnancy drug and promptly raised the price from $20 a dose to $1,500.